Scheduling Tianeptine and Analogues Now to Defend Against Emerging Opioids Act

H.R. 3520 · 119th Congress · May 20, 2025 · Lineage

A BILL

To amend the Controlled Substances Act to provide for the scheduling of tianeptine as a schedule III substance, and for other purposes.

Section 1 Short title

This Act may be cited as the “Scheduling Tianeptine and Analogues Now to Defend Against Emerging Opioids Act” or the “STAND Against Emerging Opioids Act”.

Sec. 2 Scheduling of tianeptine

(a)

In general— Section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) is amended by adding at the end of schedule III the following:

“(f) Tianeptine, including its analogues, salts, isomers, and salts of isomers.”

(b)

Effective date— The amendment made by subsection (a) shall become effective on the date that is 90 days after the date of enactment of this Act.

Lineage

May 20, 2025viewing Introduced in House Mr. Panetta (for himself and Mr. Pfluger) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

Scheduling Tianeptine and Analogues Now to Defend Against Emerging Opioids Act

Section 1 Short title

Sec. 2 Scheduling of tianeptine

Cite this provision

Incoming references